viernes, 5 de octubre de 2018

Why is this drug pricing PAC spending millions on long-shot races? - STAT

Why is this drug pricing PAC spending millions on long-shot races? - STAT

Morning Rounds

Inside STAT: Why is a PAC spotlighting high drug prices sinking millions into unwinnable races?

3c3c03eb-ead2-4257-b1a7-8430ed411081.png

(ALEX HOGAN / STAT)
Patients for Affordable Drugs has poured at least $8 million to highlight high drug prices in midterm race — but a significant chunk of that has gone to campaigns where the money won't make a difference. The group says the money can still send a message: Politicians can't run campaigns funded by drug companies without consequences. Not everyone is convinced that making politicians hesitate before accepting a check from pharma will happen any time soon. “It’s going to be years before somebody runs in this state or that with a major biotech presence [and says] they’re not going to accept [drug industry] funding," says Harvard's Bob Blendon, who studies the politics of health care. STAT's Rebecca Robbins and Lev Facher have the story here

No hay comentarios: